Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

17

Number of overlapping holdings

19.3%

% of WDNA's 91 holdings also in ARKG

51.5%

% of ARKG's 35 holdings also in WDNA

Overlap by Weight
Sector Drift (WDNA minus ARKG)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in WDNA
Weight
in ARKG
Overlap
TWIST BIOSCIENCE CORP. 4.3% 9.2% 4.3%
NATERA INC 2.2% 5.0% 2.2%
IONIS PHARMACEUTICALS, INC. 1.4% 3.9% 1.4%
AMGEN INC 1.4% 1.6% 1.4%
BEAM THERAPEUTICS, INC. 1.4% 4.3% 1.4%

Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to ARKG
NOVOZYMES A/S-B SHARES 2.7%
BLUEPRINT MEDICINES CORP. 2.6%
GERON CORP 2.5%
AGIOS PHARMACEUTICALS INC 2.4%
FATE THERAPEUTICS INC 2.2%
VERICEL CORPORATION 2.1%
ELI LILLY & CO 2.1%
IOVANCE BIOTHERAPEUTICS INC 1.7%
SAREPTA THERAPEUTICS INC 1.7%
BRIDGEBIO PHARMA, INC. 1.6%
WDNA Underweight Relative to ARKG
RECURSION PHARMACEUTICALS, INC CLASS -7.2%
CRISPR THERAPEUTICS AG -5.6%
ADAPTIVE BIOTECHNOLOGIES CORP. -5.6%
TWIST BIOSCIENCE CORP. -4.9%
CAREDX, INC. -4.9%
GUARDANT HEALTH, INC. -4.5%
VERACYTE INC -4.0%
SCHRODINGER, INC. -3.3%
10X GENOMICS INC CLASS A -3.0%
BEAM THERAPEUTICS, INC. -2.9%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY